The Adoption of R in Japan's Pharma Industry Confirmation

The Adoption of R in Japan’s Pharma Industry talk and panel discussion was led by key industry experts from the JPMA R Task Force Team. The webinar explored the usage and adoption of R in the pharmaceutical industry, specifically focusing on the findings of the JPMA Drug Evaluation Committee, R Task Force Team, and the JPMA Report. The report referenced various open source works and publications, including those from the R Consortium pilot submissions, Package Validation Hub, and webinar training.

Agenda:
General Background by Rikimaru Nishimura
PMDA: Highlighting the intricacies of submissions with R.
JPMA R Task Force: Delving into past activities and shedding light on future initiatives.
JPMA Survey Report by Rikimaru and Yuki Matsunaga
Background: Understanding the rationale and motivation behind the JPMA survey.
Results: Discuss key findings and their implications for the industry.
Q&A Session

#Rstats #Opensource #rprogramming

Main Sections

00:00 Introduction
04:54 General Background by Rikimaru Nishimura
13:11 JPMA Survey Report by Rikimaru and Yuki Matsunaga
26:56 Conclusion
27:47 Q&As

More Resources

Main Site: https://www.r-consortium.org/
DataTrail: https://www.datatrail.org/
Blog: https://www.r-consortium.org/news/blog
Join: https://www.r-consortium.org/about/join
LinkedIn:   / r-consortium  
Twitter: https://twitter.com/rconsortium?lang=en
Mastodon: https://fosstodon.org/@RConsortium